By Katie Reid
ZURICH |
Thu Feb 10, 2011 1:21pm EST
ZURICH (Reuters) - Novartis and its Sandoz unit, maker of a generic version of an anesthetic used in lethal injections in the United States, have taken steps to try to stop the drug ending up in the United States.
"Sandoz has also advised all of its subsidiaries with locally approved marketing authorizations for sodium thiopental to not sell the product to distributors or third parties that
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment